Genpharmasec Ltd. - Research Center
531592 GENPHARMA Group (XT) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
10.20 |
6.38 |
7.86 |
5.96 |
6.22 |
Operating profit |
0.16 |
0.02 |
-0.04 |
0.02 |
0.21 |
Interest |
0.14 |
0.12 |
0.07 |
0.06 |
0.06 |
Gross profit |
0.33 |
0.03 |
0.05 |
0.07 |
0.21 |
EPS (Rs) |
- |
- |
- |
- |
0.04 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
0.31 |
0.14 |
0.15 |
0.11 |
0.06 |
Stock adjustment |
0.49 |
1.05 |
1.03 |
-1.73 |
-0.99 |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.16 |
0.23 |
0.17 |
0.20 |
0.17 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
9.38 |
5.09 |
6.70 |
7.48 |
6.83 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
- |
- |
- |
0.01 |
0.01 |
Taxation |
0.38 |
-0.03 |
0.04 |
0.04 |
-0.84 |
Net profit / loss |
-0.05 |
0.06 |
0.01 |
0.03 |
1.05 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
55.37 |
27.69 |
27.69 |
27.69 |
27.69 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
1.59 |
0.26 |
-0.52 |
0.38 |
3.32 |
GPM (%) |
3.15 |
.53 |
.58 |
1.18 |
3.32 |
NPM (%) |
-0.49 |
0.97 |
0.10 |
0.43 |
16.67 |